Loading...

Elanco Animal Health Incorporated

ELANNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$14.93
$0.25(1.70%)

Elanco Animal Health Incorporated (ELAN) Stock Overview

Explore Elanco Animal Health Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.3/100

Key Financials

Market Cap7.4B
P/E Ratio19.82
EPS (TTM)$0.75
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Week$14.22
1 Month$9.55
3 Months$10.63
1 Year Target$14.59

ELAN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Elanco Animal Health Incorporated (ELAN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.06, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.59.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.82 and a market capitalization of 7.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;